10 terminated. 10 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 10 | Terminated 10 |
| Phase 2 | 2 | Terminated 2 |
Follow Hyperglycemia: new trials by email Literature Review of Hyperglycemia trials Research Report on Hyperglycemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess Safety, Tolerability, and Pharmacokinetics of AZD0186 AZD0186, Placebo - Type 2 Diabetes | Phase 1 | Terminated | AstraZeneca | 31 | 2022-12-20 | 2024-12-13 |
| Glucagon Receptor Inhibition to Enable Breast Cancer Patients to Benefit From PI3K Inhibitor Therapy (REMD-477) REMD-477 - Hyperglycemia Drug Induced | Phase 1 | Terminated | Duke University | 1 | 2020-11-13 | 2022-11-08 |
| Effect of 1,25-dihydroxyvitamin D3, Treatment on Insulin Secretion and Muscle Strength in Pre-diabetic Persons Calcitriol capsules, Oral Placebo - Pre-Diabetic | Phase 1 | Terminated | Mayo Clinic | 17 | 2020-10-01 | 2022-04-18 |
| Pioglitazone Treatment for Hyperglycemic Acute Ischemic Stroke Pioglitazone 45 mg, Placebo oral tablet - Stroke, Acute, Hyperglycemia | Phase 1 / Phase 2 | Terminated | Milton S. Hershey Medical Center | 1 | 2020-09-01 | 2022-09-15 |
| A Study to Determine Safety and Efficacy of (REMD-477) in Controlling Hyperglycemia Due to Copanlisib REMD-477 - Hyperglycemia Drug Induced | Phase 1 | Terminated | Duke University | 1 | 2020-04-07 | 2021-06-11 |
| Glucagon Response to Prandial Insulin Administration in Persons With Type 1 Diabetes Insulin - Type 1 Diabetes, Hyperglycemia, Postprandial | Phase 1 / Phase 2 | Terminated | Washington University School of Medicine | 1 | 2020-02-13 | 2022-10-07 |
| Examination of the Metabolic Effects of Direct Bile Salt Delivery to the Ileum in Humans Ursodeoxycholic Acid, Placebos - Glucose Intolerance, Gastric Bypass Surgery | Phase 1 | Terminated | Vanderbilt University Medical Center | 2 | 2018-02-01 | 2021-04-20 |
| Sleep Effectiveness and Insulin and Glucose Homeostasis eszopiclone - Diabetes, Prediabetic | Phase 1 | Terminated | Beth Israel Deaconess Medical Center | 20 | 2012-10-01 | 2019-12-19 |
| GLU-xx Formulations in Individuals With Impaired Glucose Tolerance GLU-01, GLU-02, GLU-03 - Impaired Glucose Tolerance | Phase 1 | Terminated | Afexa Life Sciences Inc | 17 | 2011-02-01 | 2012-01-31 |
| Vascular Function, Endothelin, and Inflammation in Pre-diabetic Obesity Versus Lean Healthy Controls Chronic salsalate, Acute Salsalate - Pre-diabetes, Obesity | Phase 1 | Terminated | Indiana University | 16 | 2009-03-01 | 2019-08-01 |
Glucose Intolerance (5) · Diabetes Mellitus (2) · Breast Neoplasms (1) · Diabetes Mellitus, Type 1 (1) · Diabetes Mellitus, Type 2 (1) · Hereditary Sensory and Autonomic Neuropathies (1) · Lymphoma (1) · Obesity (1) · Prediabetic State (1) · Sleep Initiation and Maintenance Disorders (1) · Stroke (1)
Glucose Metabolism Disorders (10) · Metabolic Diseases (10) · Nutritional and Metabolic Diseases (10) · Endocrine System Diseases (4) · Nervous System Diseases (3) · Diabetes Mellitus (2) · Immune System Diseases (2) · Neoplasms (2) · Autoimmune Diseases (1) · Body Weight (1) · Brain Diseases (1) · Breast Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1)
volagidemab (2) · Calcitriol (1) · Eszopiclone (1) · Insulin (1) · Pioglitazone (1) · Sodium Chloride (1) · Ursodeoxycholic Acid (1)
Duke University (2) · Afexa Life Sciences Inc (1) · AstraZeneca (1) · Beth Israel Deaconess Medical Center (1) · Indiana University (1) · Mayo Clinic (1) · Milton S. Hershey Medical Center (1) · Vanderbilt University Medical Center (1) · Washington University School of Medicine (1)
United States (10)
Esther Yoon, MD (1) · Janet McGill, MD (1) · Jay Udani, MD (1) · Kerstin Bettermann, MD, PhD (1) · Kieren J Mather, MD (1) · Melanie Pogach, MD (1) · Naji Abumrad, MD (1) · Rajiv Kumar, MD (1) · Susan Dent, MD (1)